Psychiatry
As use of widely prescribed stimulants increases, experts see troubling parallels to opioid crisis.
19 Aug, 2021 | 08:46h | UTC
[Preprint] Impact of the COVID-19 pandemic on early child cognitive development: initial findings in a longitudinal observational study of child health.
16 Aug, 2021 | 01:11h | UTC
Commentary on Twitter (thread – click for more)
Preprint on the development of children born before and during the pandemic in the US.
"We find that children born during the pandemic have significantly reduced verbal, motor, and overall cognitive performance compared to children born pre-pandemic."
1/https://t.co/NInexSUDAi— Prof Francois Balloux (@BallouxFrancois) August 15, 2021
Opinion: A call to revise the diagnosis of oppositional defiant disorder—diagnoses are for helping, not harming.
16 Aug, 2021 | 00:48h | UTCA Call to Revise the Diagnosis of Oppositional Defiant Disorder—Diagnoses Are for Helping, Not Harming – JAMA Psychiatry (free for a limited period)
Commentary on Twitter
Can giving someone a diagnosis (more accurately, a diagnostic label) cause harm? Undoubtedly; an example is discussed in this article https://t.co/13RysG9Yxa In rehabilitation, the term 'functional disorder' often stigmatises, & many labels generate unfair expectations in others
— Derick Wade (@derickwaderehab) August 14, 2021
European guideline and expert statements on the management of narcolepsy in adults and children.
13 Aug, 2021 | 09:02h | UTC
M-A: More than 50 long-term effects of COVID-19.
11 Aug, 2021 | 08:47h | UTCRelated:
Cohort study: Risk factors for long covid in previously hospitalized children.
Viewpoint: The road to addressing Long Covid.
Review: Long covid—mechanisms, risk factors, and management.
Review: Symptoms, complications and management of long COVID.
Studies elucidate poorly understood long COVID.
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
[Preprint] Long Covid: Third of people infected have long term symptoms.
Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Perspective | The four most urgent questions about long COVID.
Systematic review: Frequency, signs and symptoms, and criteria adopted for long COVID-19.
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
One third of patients hospitalized with COVID-19 have lung changes after a year
Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
Long Covid Implications for the workplace
Long Covid in the UK – More than a million affected in February, survey suggests
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Review | Post-acute COVID-19 syndrome
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Perspective | Long Covid isn’t as unique as we thought
Attributes and predictors of long COVID
WHO Report: Preparing for Long COVID 2021
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
How many people get ‘long COVID’ – and who is most at risk?
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Patients, clinicians seek answers to the mystery of ‘Long COVID’
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
NICE Guideline: Managing the long-term effects of COVID-19
Commentary on Twitter
https://twitter.com/svillapol/status/1425032774793285648
New WHO toolkit promotes inclusion of people with dementia in society.
11 Aug, 2021 | 08:31h | UTCNew WHO toolkit promotes inclusion of people with dementia in society – World Health Organization
See Guidance: Towards a dementia inclusive society: WHO toolkit for dementia-friendly initiatives (DFIs) – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 toolkit to promote a #dementia-inclusive society launched. It will helps countries raise public awareness and understanding of dementia to support people living with dementia to remain in, and be a significant part of, their communities.
👉 https://t.co/blpDQHUSWM pic.twitter.com/D5MIM5jdlr
— World Health Organization (WHO) (@WHO) August 10, 2021
M-A: Child and youth mental health problems have doubled during COVID-19.
10 Aug, 2021 | 10:03h | UTCCommentary: Child and youth mental health problems have doubled during COVID-19 – The Conversation
Original study: Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19: A Meta-analysis – JAMA Pediatrics
Editorial: Addressing the Global Crisis of Child and Adolescent Mental Health – JAMA Pediatrics
Related:
More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.
COVID has caused ‘mass trauma,’ worsening mental health globally.
COVID’s mental-health toll: how scientists are tracking a surge in depression
WHO: COVID-19 disrupting mental health services in most countries
Commentary on Twitter (thread – click for more)
Many are rightfully sounding the alarm to a youth #mentalhealth crisis. Our meta-analysis of 29 studies w >80,000 youth worldwide in @JAMAPediatrics, shows 1 in 4 youth had elevated depression or anxiety during #COVID19. A thread 🧵 https://t.co/etIdZTHnme
— Dr. Sheri Madigan (she/her) (@sherimadigan) August 9, 2021
Perspective | Expertise from outside the Academy: tapering off antidepressants.
8 Aug, 2021 | 23:27h | UTCExpertise from outside the Academy: tapering off antidepressants – The Mental Elf
Related:
A method for tapering antipsychotic treatment that may minimize the risk of relapse
Systematic Review: Managing Antidepressant Discontinuation
Randomized controlled trial: preventive cognitive therapy for prevention of depressive recurrence
AAP Interim guidance on supporting the emotional and behavioral health needs of children, adolescents, and families during the COVID-19 pandemic.
4 Aug, 2021 | 10:03h | UTC
Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.”
4 Aug, 2021 | 09:07h | UTCSee also:
Commentary:
More evidence needed to back cannabis as pain treatment, says review – Imperial College London
Medicinal cannabis to manage chronic pain? We don’t have evidence it works – The Conversation
Related:
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
RCT: Routine treatment with fluoxetine does not reduce the incidence of depression after stroke.
4 Aug, 2021 | 08:56h | UTCDepression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial – JAMA Neurology (free for a limited period)
Editorial: Poststroke Selective Serotonin Reuptake Inhibitors—Do They Work for Anything? (free for a limited period)
Related:
[Abstract Only] Randomized trial: Fluoxetine does not improve functional recovery after acute stroke
Randomized Trial: Effects of Fluoxetine on Functional Outcomes After Acute Stroke
Study: Patients who have recovered from COVID-19 may have persistent cognitive symptoms.
30 Jul, 2021 | 12:03h | UTCCognitive deficits in people who have recovered from COVID-19 – EClinicalMedicine
Commentary on Twitter (thread – click for more)
We assessed thousands and saw clear evidence of cognitive deficits in people who have recovered from COVID-19. Took a while to appease peer reviewers, but the results stand. Brilliantly led by @HampshireHub. @Amy2Jolly @JoeBarnby @srchamb @neurohellyer https://t.co/AnbhanixRk
— mitul mehta (@mehta_mitul72) July 23, 2021
Self-reported memory problems 8 months after COVID-19 infection.
30 Jul, 2021 | 12:02h | UTCSelf-reported Memory Problems 8 Months After COVID-19 Infection – JAMA Network Open
Commentary: Post-acute Sequelae of SARS-CoV-2 Infection and Subjective Memory Problems – JAMA Network Open
Commentary on Twitter (thread – click for more)
Concerning data out now in @JAMANetworkOpen about cognitive symptoms in #LongCovid among *non-hospitalized* adults.
Researchers in Norway invited 35,000 adults at the time of #coronavirus testing as well as a 20,000 person untested random sample to a prospective cohort.
(1/6) pic.twitter.com/AaU5rrwaPw
— F. Perry Wilson, MD MSCE (@fperrywilson) July 29, 2021
Systematic review and meta-analysis of depression, anxiety, and suicidal ideation among Ph.D. students.
28 Jul, 2021 | 09:54h | UTC
Commentaries on Twitter
A study in @SciReports concludes that depression and anxiety are highly prevalent among PhD students and programs to monitor and promote mental health are urgently needed. https://t.co/zTWxGC4Rs0 pic.twitter.com/tINXMmeJWj
— Nature Portfolio (@NaturePortfolio) July 27, 2021
*New* meta-analysis of >15K PhD students finds that 24% have clinical symptoms of depression & 17% of anxiety.
As a baseline: The prevalence of major depression among young adults in the US is ~13% & anxiety disorder is 4%.
Ht @wormmaps https://t.co/QPxHj0tgTc
— Amy Maxmen, PhD (@amymaxmen) July 13, 2021
M-A: Psychiatric patients at increased risk of COVID-19 hospitalization and mortality.
26 Jul, 2021 | 02:57h | UTCNews release: Psychiatric patients at increased risk of COVID-19 hospitalization and mortality – European College of Neuropsychopharmacology
RCT: Comparison of nebulized ketamine at three different dosing regimens for treating painful conditions in the emergency department.
13 Jul, 2021 | 09:22h | UTCComparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the Emergency Department: A Prospective, Randomized, Double-Blind Clinical Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Nebulized Ketamine for pain in the ED? No way…Well- here you go-Comparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the ED. https://t.co/v3UT0Y0LdU #FOAMed #FOAMems #FOAMtox #FOAMcc #FOAMpharm
— Sergey Motov (@painfreeED) July 3, 2021
M-A: Continuation of antidepressants vs. sequential psychological interventions to prevent relapse in depression.
8 Jul, 2021 | 08:50h | UTCContinuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries: Cognitive Therapy While Tapering Antidepressants May Be Alternative to Maintenance Medication – Psychiatric News Alert AND Psychotherapy Can Prevent Relapse When Discontinuing Antidepressants – Mad in America
Commentary on Twitter
Sequential delivery of a psychological intervention while tapering antidepressants may be a potential alternative to long-term medication use in recurrent #depression, regardless of clinical risk factors @JosefienUMH, @Claudib123 https://t.co/UURRmv6qQO
— JAMA Psychiatry (@JAMAPsych) May 19, 2021
RCT: A prevention program for insomnia in at-risk adolescents.
7 Jul, 2021 | 08:38h | UTCA Prevention Program for Insomnia in At-risk Adolescents: A Randomized Controlled Study – Pediatrics (link to abstract – $ for full-text)
Commentaries: Using a program to combat teen insomnia – Contemporary Pediatrics AND Cognitive behavioral program may prevent insomnia in at-risk adolescents – Medicom
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations.
5 Jul, 2021 | 01:30h | UTCAntipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations – Drugs
The Management of Restless Legs Syndrome: An Updated Algorithm
2 Jul, 2021 | 11:12h | UTCThe Management of Restless Legs Syndrome: An Updated Algorithm – Mayo Clinic Proceedings
Perspective | “Prohibitive policies cause more problems than illict drugs, say experts”
2 Jul, 2021 | 11:07h | UTCProhibitive Policies Cause More Problems Than Illict Drugs, Say Experts – Health Policy Watch
The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection.
1 Jul, 2021 | 09:55h | UTC
Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department.
28 Jun, 2021 | 09:43h | UTC
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
25 Jun, 2021 | 10:33h | UTCOriginal Study: Long COVID in a prospective cohort of home-isolated patients – Nature Medicine
Commentary on Twitter
Analysis of a prospectively enrolled cohort of patients with #SARSCoV2 infections reveals a high proportion who experienced #LongCovid symptoms at 6 months, despite being relatively young and having only mild to moderate acute #COVID19 symptoms https://t.co/fuW2QpfJog
— Nature Medicine (@NatureMedicine) June 23, 2021
One in 100 deaths is by suicide – WHO guidance to help the world reach the target of reducing suicide rate by 1/3 by 2030.
21 Jun, 2021 | 08:39h | UTCOne in 100 deaths is by suicide – World Health Organization
Report: Suicide worldwide in 2019: Global Health Estimates – World Health Organization
Commentary on Twitter (thread – click for more)
DYK: 1 in 100 deaths is by suicide.
Every year, more people die as a result of suicide than HIV, malaria or breast cancer – or war and homicide. https://t.co/PAD5Bd1dfS pic.twitter.com/TGq5BdNMNd
— World Health Organization (WHO) (@WHO) June 17, 2021